Phase II trial of adjuvant mFOLFOX6 after metastasectomy for lung metastasis of colorectal cancer

ABSTRACT: Interventions: Fluororacil/l-leucovorin plus oxaliplatin (mFOLFOX6) Primary outcome(s): 5-year survival rate Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2621130 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR